• Home
  • Search Results

Search Results

Older Adult (65+)
2120 studies match your search
Open

Stress, queer families, and microbiome

Do you identify as queer? Are you currently family planning? You may be eligible for our study. We are interested in understanding how stress and social support during family planning are related to health outcomes in queer parents and their infants. Study participation will includes interviews, survey completion, and fecal and skin microbiome collection. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Microbiome
  • Pregnancy
  • and 5 more
Coming Soon

Sparing Parotid Ducts via MRI Sialography for Reduced Patient-Reported Xerostomia

Radiation treatment for head and neck cancer can often cause a very dry mouth. This dryness can last for a long time, even after the treatment ends. In our study, we want to see if changing where the radiation is aimed can help with this dryness. If you join, you'll fill out some simple questionnaires and give saliva samples. We'll also check in with you for about a year after your treatment to see how you're doing.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
  • Ear, Nose, and Throat
Open

The REACH Study: Barriers to Health Insurance Signup

Have you ever signed up for health insurance through Healthcare.gov? If you live in North Carolina and are 18 or older, we invite you to share your thoughts! You'll earn $50 for a 45-minute interview with us.

Age & Gender
  • 18 years ~ 65 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Visit Location
100% Remote (online, phone, text)
Coming Soon

P-RAD(+)TN - DCT

You are being asked to take part in this study because you have triple negative (TN) breast cancer that has spread to your lymph nodes. You are also planning to get chemo-immunotherapy treatment before surgery. Radiation therapy (RT) has been shown to improve the body's immune response against tumors when it is given with a drug called pembrolizumab. The purpose of this study is to find the best and safest dose of radiation (low or high) when given with pembrolizumab. Radiation is measured in Gy (pronounced "gray"). You will be randomly assigned (like flipping a coin) to receive either a low dose RT boost (9 Gy) or a high dose RT boost (24 Gy). The RT will be given with one dose of pembrolizumab. This is a hybrid decentralized study where some if not all assessments may be performed close to your home.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Coming Soon

Improving health information access for rural communities

We are testing the usability of a health information website that shares easy-to-understand information about prostate cancer. The website is called iPICS. We want to see if the website is helpful for people living in rural areas, especially older adults. By working with public libraries, we hope to learn how to make the website better and easier to use. Our goal is to help people find trustworthy health information so they can make good decisions about their health.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Cancer (Prostate)
  • Men's Health
Visit Location
100% Remote (online, phone, text)
Open

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Are you a patient with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)? If so this could be the study for you. The purpose of this study is to investigate if the sonrotoclax in combination with obinutuzumab or rituximab works better and is safe in participants with

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia, Lymphoma)
Coming Soon

Exploring A Treatment Device for Liver Cancer

We're doing this study to explore how a device called TheraBionic affects people with liver cancer and their condition. This device uses special frequencies to target cancer cells and is being tested for treating advanced liver cancer.

Age & Gender
  • 22 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Liver)
  • Kidneys and Liver
Open

Live Music and Religion Study

Do you regularly attend free live music events? Do you want to talk about how awesome they are? If you're a known face at your local jazz show, you should click on this study!

Age & Gender
  • 21 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Social or Workplace Dynamics
  • UNC Students (undergrad, grad, professional)
Visit Location
100% Remote (online, phone, text)
Open

SPARX: A post kidney transplant study

Do you have a kidney transplant? Have you been diagnosed with recurrent Immunoglobulin A nephropathy (IgAN) or Focal Segmental Glomerulosclerosis (FSGS)? If so, this study may be of interest to you.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Kidneys and Liver
  • Transplant
Open

Exploring Genetics in Nursing: How Ready Are Nurses in Saudi Arabia?

Are you a nurse in Saudi Arabia? We want to hear from you! Join our UNC study to share your thoughts on using genetics in nursing. Your feedback will help shape better nursing education and support your daily work.

Age & Gender
  • 22 years ~ 75 years
  • Male, Female
Study Interest
  • Genetics and Genetic Disorders
  • Opinions and Perceptions
  • Social or Workplace Dynamics
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research